Return to Excellus Employers News

Navigating The GLP-1 Trend

Diabetes is one of the top trend drivers of pharmacy costs due to the growing diabetic population and newer, more expensive therapies recommended earlier in the treatment plan. Since 2006, medications like Ozempic® and Trulicity® have been used to treat Type 2 Diabetes. Today, they are gaining popularity as celebrities and social media influencers tout their weight loss benefits.

As a health plan committed to providing access to high-quality and affordable health care, the rising trend of GLP-1 therapies demands careful consideration.

Read The Full Article

 

 
 
RELATED NEWS:
ACTION REQUIRED: Multi-Factor Authentication Launching In The Coming Days For Employer Web Accounts

Leadership Announcement: Dr. Martin Stallone To Join Excellus BCBS Executive Team

2025 Gag Clause Attestation Process & Separate Letter Notification

2026 Individual Market Plans

2026 Annual Rate Notices Being Mailed

CATEGORY:

Excellus

Employer

Employer Specific

Small Business

Midsize & Large Business

Wellness

Script for Excellus BCBS Employer/Broker News Archive/Article

 

GDPR Notification Content